FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm UV

17,536 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 2600 - 2800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
smart.who.int.base-clinicalR4ImplementationGuide/smart.who.int.base-clinicalSMART Base Clinicaldraft2025-06who
hl7.fhir.uv.cqlR4ImplementationGuide/hl7.fhir.uv.cqlUsing CQL With FHIRtrial-use4cds2024-06hl7
hl7.fhir.uv.cmiR4ImplementationGuide/hl7.fhir.uv.cmiContent Management Infrastructure Implementation Guidedraft2022-05hl7
hl7.fhir.uv.crmiR4ImplementationGuide/hl7.fhir.uv.crmiCanonical Resource Management Infrastructure Implementation Guideactivecds2024-05hl7
hl7.fhir.uv.crmiR4ImplementationGuide/publishable-examplePublishable ImplementationGuide Exampledraft2023-07hl7
hl7.fhir.uv.crmiR4ImplementationGuide/shareable-exampleShareable ImplementationGuide Exampledraft2023-07hl7
hl7.fhir.uv.cqlR4ImplementationGuide/exampleCQL ImplementationGuide Exampledraft2023-07hl7
smart.who.int.ancR4ImplementationGuide/smart.who.int.ancWHO Antenatal Care Guideline Implementation Guidedraft2017-02who
hl7.fhir.uv.cmhaffr2R5ImplementationGuide/hl7.fhir.uv.cmhaffr2Consumer Mobile Health Application Functional Framework, Release 2informative1mobile2025-05hl7
hl7.fhir.uv.vhdirR4ImplementationGuide/hl7.fhir.uv.vhdirValidated Healthcare Directorytrial-use2pa2022-02hl7
hl7.ehrs.uv.ehrsfmr2R5ImplementationGuide/hl7.ehrs.uv.ehrsfmr2HL7 Electronic Health Record System Functional Model, Release 2.1.1normative1ehr2025-05hl7
ihe.iti.deidR4ImplementationGuide/ihe.iti.deidDe-Identification Profiledraft2025-07ihe
hl7.fhir.uv.mhealth-frameworkR4ImplementationGuide/hl7.fhir.uv.mhealth-frameworkApplication Data Exchange Assessment Framework and Functional Requirements for Mobile Healthactive2020-04hl7
ihe.iti.dsubmR4ImplementationGuide/ihe.iti.dsubmDocument Subscription for Mobile (DSUBm)active2025-04ihe
ihe.pcc.rsqR4ImplementationGuide/ihe.pcc.rsqIHE PCC Referral Status Querydraft2024-07ihe
ihe.domain.profileR4ImplementationGuide/ihe.domain.profilespelled out name of the IHE Profiledraft2025-03ihe
ihe.pcc.apsR4ImplementationGuide/ihe.pcc.apsAntepartum Summarydraft2023-10ihe
xxxexample.fhir.uv.myigR4ImplementationGuide/xxxexample.fhir.uv.myigxxxYour User Friendly Name for MyIG Heredraft2025-07
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-1Bystander Chest Compressionsunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-10TBDunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-2Dispatch coached chest compressionsunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-3Time from PSAP to initial compressionsunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-4Time to initial shockunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-5Average chest compression rateunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-6Average chest compression depthunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-7Return of Spontaneous Circulation (ROSC)during EMS careunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-8Survival of OHCA with all presenting rhythmsunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-9Survival of OHCA when witnessed by bystanderunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Hypoglycemia-01Treatment Administered for Hypoglycemiaunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Hypoglycemia-02Improved Post-Treatment Conditionunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Hypoglycemia-03Hypoglycemic Patients Treated and not Transportedunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Hypoglycemia-04Repeat Response for Patient Previously Not Transportedunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-01Percentage of suspected opioid OD patients who received Narcanunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-02Percentage of suspected opioid OD patients transported to an EDunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-03Percentage of suspected opioid OD patients given multiple Narcan doses in case of an “Unchanged” response to the first doseunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-04Percentage of suspected opioid OD patients experiencing a repeat OD within a specified time period.unknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-05Percentage of suspected opioid OD patients with a recorded combination of altered mental status, poor respiratory effort (RR<12 per minute), and pin point pupils.unknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-06Percentage of suspected opioid OD patients with a specific opioid recordedunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-07Percentage of suspected opioid OD patients experiencing an Increase in pulse oximetry after EMS care.unknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-08Percentage of suspected opioid OD patients experiencing an Increase in Glasgow Coma Scale (GCS) after EMS care.unknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-09Percentage of suspected opioid OD patients experiencing an Increase in respiratory rate after EMS care.unknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-10Percentage of suspected opioid OD patients who received ventilatory support within five minutes of first EMS unit’s arrival on scene.unknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-11Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administrationunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-PEDS-01Respiratory Assessment - Pediatricunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-PEDS-02Administration of beta agonist for pediatric asthmaunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-PEDS-03Documentation of estimated weight in kilograms - pediatricunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-PEDS-04Medication error rateunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-1Time to first EKGunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-2Time to receiving facility pre-notificationunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-3Transport to PCI/Thrombolytic capable facilitiesunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-4Time from First medical contact to receiving facilityunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-5Patients with complete bundle of careunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-6EMS correctly identified STEMIunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-7Time to Reperfusionunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-01Lights and Sirens Response to Scene Rateunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-02Lights and Sirens Transport Rateunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-03Number of crashesunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-04Number of crashes resulting in injuryunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-05Number of fatal crashesunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-06Rate of crashes per 100,000miunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-07Rate of crashes resulting in injury per 100,000miunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-08Rate of fatalities per 100,000miunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Seizure-01Blood Glucose Evaluationunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Seizure-02Patient Received Interventionunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Seizure-03Patients with Terminated Seizuresunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-01Suspected Stroke Receiving Prehospital Stroke Assessmentunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-02Blood Glucose Measurement for Patients with a Provider Impression of Strokeunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-03Prehospital Notificationunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-04Positive Stroke Assessments Transported to a Hospital Verified, Designated or Otherwise Identified as Acute Stroke-Ready or Higherunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-05Provider Impression of Stroke with Last Known Well (LKW) Documented unknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-06Prehospital Stroke Care Bundleunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-07For Patients with Positive Stroke Assessment, Average Time from Last Known Well to Arrival at a Hospital Verified, Designated or Otherwise Identified as Acute Stroke-Ready or Higherunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-08Emergency Department Diagnosed Stroke Identified by Prehospital Stroke Assessment unknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Trauma-01Pain assessment of injured patientsunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Trauma-02Pain re-assessment of injured patientsunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Trauma-03Effectiveness of pain management for injured patientsunknown2024-10ihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Trauma-04Trauma patients transported to trauma centerunknown2024-10ihe
ihe.palm.rpcR4Measure/MeasureBreastDistanceFromTheNippleBreast Distance from the Nipple Rad Path Correlationdraft2023-06ihe
ihe.palm.rpcR4Measure/MeasureBreastLateralityBreast Laterality Rad Path Correlationdraft2023-06ihe
ihe.palm.rpcR4Measure/MeasureBreastLocationOfLesionBreast Location of Lesion Rad Path Correlationdraft2023-06ihe
ihe.palm.rpcR4Measure/MeasureBreastQuadrantAndClockFaceBreast Quadrant and Clock Face Rad Path Correlationdraft2023-06ihe
ihe.palm.rpcR4Measure/MeasureGleasonGleason Score Rad Path Correlationdraft2023-06ihe
ihe.palm.rpcR4Measure/MeasureProstateLesionSizeProstate Lesion Size Rad Path Correlationdraft2023-06ihe
ihe.palm.rpcR4Measure/MeasureProstateSizeProstate Size Rad Path Correlationdraft2023-06ihe
ihe.palm.rpcR4Measure/MeasureProstateTumorLocationProstate Tumor Location Rad Path Correlationdraft2023-06ihe
hl7.fhir.uv.cqmR4Measure/age-stratified-exampleMeasure Age Stratified Exampledraft2025-06hl7
hl7.fhir.uv.cqmR4Measure/measure-pi-exmEXM Promoting Interoperability Measureactive2023-05hl7
hl7.fhir.uv.cqmR4Measure/EXMLogic-FHIREXM Measureactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/EXMRatio-FHIREXM Ratio Measureactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/measure-publishable-exmEXM Publishable Measureactivecqi2022-02hl7
hl7.fhir.uv.cpgR4Measure/chf-bodyweight-change-measureCHF Body Weight Change Metricactive2024-11hl7
hl7.fhir.uv.cpgR4Measure/chf-bodyweight-measureCHF Body Weight Metricactive2024-11hl7
hl7.fhir.uv.cpgR4Measure/activity-example-generatereport-measureActivity Example Generate Report Measureactive2023-10hl7
example.fhir.uv.mycontentigR4Measure/QuestionnaireMeasureExampleQuestionnaire Measure Exampledraft2025-04hl7
ihe.qrph.madxR4Measure/madx-hiv-indicator-example1mADX-Measure-example1draft2024-08ihe
ihe.qrph.madxR4Measure/madx-hiv-indicator-example2mADX-Measure-example2draft2024-08ihe
example.fhir.uv.mycontentigR4Measure/DischargedonAntithromboticTherapyFHIRExampleDischarged on Antithrombotic Therapy FHIR Exampledraft2025-04hl7
hl7.fhir.uv.cqmR4Measure/EXM130-FHIREXM130 - Colorectal Cancer Screening Measureactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/EXM146-FHIREXM146 - Appropriate Testing for Children with Pharyngitisactive2022-02hl7
example.fhir.uv.mycontentigR4Measure/HIVViralSuppressionFHIRExampleHIV Viral Suppression FHIR Exampledraft2025-04hl7
smart.who.int.ancR4Measure/ANCIND12ANC.IND.12 Percentage of pregnant women counselled and tested for HIVdraft2025-06who
smart.who.int.ancR4Measure/ANCIND03ANC.IND.03 Percentage of pregnant women screened for syphilis during ANCdraft2025-06who
smart.who.int.ancR4Measure/ANCIND02ANC.IND.02 Percentage of pregnant women who received iron and folic acid (IFA) supplements for 90+ daysdraft2025-06who
smart.who.int.ancR4Measure/ANCIND13ANC.IND.13 Percentage of pregnant women who received oral pre-exposure prophylaxis (PrEP)draft2025-06who
smart.who.int.ancR4Measure/ANCIND05ANC.IND.05 Percentage of pregnant women with a minimum of eight antenatal care contactsdraft2025-06who
smart.who.int.ancR4Measure/ANCIND10ANC.IND.10 Percentage of pregnant women with an ultrasound scan before 24 weeksdraft2025-06who
smart.who.int.ancR4Measure/ANCIND04ANC.IND.04 Percentage of pregnant women with at least four ANC contactsdraft2025-06who
smart.who.int.ancR4Measure/ANCIND07ANC.IND.07 Percentage of pregnant women with at least one blood pressure measure during ANCdraft2025-06who
smart.who.int.ancR4Measure/ANCIND08ANC.IND.08 Percentage of pregnant women with at least one blood pressure measure in the third trimester during ANCdraft2025-06who
hl7.fhir.uv.crmiR4Measure/publishable-exampleANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester (Publishable Example)draft2023-03hl7
hl7.fhir.uv.crmiR4Measure/shareable-exampleANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester (Shareable Example)draft2023-03hl7
smart.who.int.ancR4Measure/ANCIND01ANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimesterdraft2025-06who
hl7.fhir.uv.cqmR4Measure/EXM124-FHIREXM124 - Cervical Cancer Screeningactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/EXM125-FHIREXM125 - Breast Cancer Screeningactive2022-02hl7
smart.who.int.ancR4Measure/ANCIND11ANC.IND.11 Percentage of women who received three doses or more of intermittent preventive therapy for malaria (IPTp) during their last pregnancydraft2025-06who
smart.who.int.ancR4Measure/ANCIND09ANC.IND.09 Percentage of pregnant women whose baby’s heartbeat was listened to at least once during ANCdraft2025-06who
smart.who.int.ancR4Measure/ANCIND06ANC.IND.06 Pregnant women who received counselling on danger signs (%) during at least one ANC contactdraft2025-06who
hl7.fhir.uv.sanerR4Measure/CDCHealthcareSupplyPathwayCOVID-19 Healthcare Supply Pathwaydraft2020-04hl7
hl7.fhir.uv.sanerR4Measure/CDCHealthcareWorkerStaffingPathwayCOVID-19 Healthcare Worker Staffing Pathwaydraft2020-04hl7
hl7.fhir.uv.cqmR4Measure/PreventiveCareandWellnessPatientLevelLinearCompositePreventive Care and Wellness Patient-level Linear Compositedraft2025-07hl7
hl7.fhir.uv.cqmR4Measure/PreventiveCareandWellnessWeightedCompositePreventive Care and Wellness Weighted Compositedraft2025-07hl7
hl7.fhir.uv.cqmR4Measure/PreventiveCareandWellnessAllOrNothingCompositePreventive Care and Wellness All-Or-Nothing Compositedraft2025-07hl7
hl7.fhir.uv.cqmR4Measure/PreventiveCareandWellnessOpportunityCompositePreventive Care and Wellness Opportunity Compositedraft2025-07hl7
hl7.fhir.uv.cqmR4Measure/EXM55-FHIREXM55 - Median Emergency Department Visit Durationactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/measure-risk-adjustment-FHIR2Risk Adjustment FHIR DSTU2active2019-02hl7
hl7.fhir.uv.cqmR4Measure/Terminology-FHIRTerminology FHIRactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/BCSComponentBreast Cancer Screeningactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/HBPComponentPreventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documentedactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/PVSComponentPneumococcal Vaccination Status for Older Adultsactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/TSCComponentPreventive Care and Screening: Tobacco Use: Screening and Cessation Interventionactive2022-02hl7
hl7.fhir.uv.cqmR4Measure/CCSComponentCervical Cancer Screeningactive2022-02hl7
example.fhir.uv.mycontentigR4Measure/HybridHospitalWideMortalityFHIRExampleCore Clinical Data Elements for the Hybrid Hospital-Wide (All-Condition, All-Procedure) Risk-Standardized Mortality Measure (HWM) FHIR Exampledraft2025-04hl7
hl7.fhir.uv.cqmR4Measure/EXM108-FHIREXM108 - Venous Thromboembolism Prophylaxisactive2022-02hl7
hl7.fhir.uv.sanerR4Measure/PatientsByRiskFactorWithSupplementalDataCOVID-19 Patients By Risk Factordraft2024-05hl7
hl7.fhir.uv.sanerR4Measure/ComputableCDCPatientImpactAndHospitalCapacityPatient Impact and Hospital Capacitydraft2024-05hl7
hl7.fhir.uv.sanerR4Measure/FEMADailyHospitalCOVID19ReportingFEMA Laboratory Orders and Results Daily Increase Reportingdraft2024-05hl7
hl7.fhir.uv.sanerR4Measure/CDCPatientImpactAndHospitalCapacityPatient Impact and Hospital Capacitydraft2024-05hl7
hl7.fhir.uv.cqmR4Measure/MultiRateExample-FHIRMulti-Rate Example Measuredraft2022-02hl7
hl7.fhir.uv.cpgR4Measure/chf-urine-out-measureCHF Urine Out Metricactive2024-11hl7
hl7.fhir.uv.order-catalogR5MessageDefinition/example-message-definition-initializeMessage definition (re)initializing the catalog of message receiveractive2020-04hl7
hl7.fhir.uv.order-catalogR5MessageDefinition/example-message-definition-updateMessage definition updating the catalog of message receiveractive2020-04hl7
ihe.iti.pmirR4MessageDefinition/IHE.PMIR.MessageDefinition.ResponsePMIR Mobile Patient Identity Feed [ITI-93] MessageDefinition Responseactive2022-03ihe
ihe.iti.pmirR4MessageDefinition/IHE.PMIR.MessageDefinitionPMIR Mobile Patient Identity Feed [ITI-93] MessageDefinitionactive2022-03ihe
hl7.terminologyR5NamingSystem/v3-PeriodicIntervalOfTimeAbbreviationPeriodicIntervalOfTimeAbbreviationretired2019-03hl7
hl7.terminologyR5NamingSystem/USDEANumberUnited States Drug Enforcement Agency (DEA) Numberactive2024-06hl7
hl7.terminologyR5NamingSystem/FEIFDA Establishment Identifieractive2024-10hl7
hl7.terminologyR5NamingSystem/CDCVISVaccine Information Statements (VIS)active2025-02hl7
hl7.terminologyR5NamingSystem/CDCLocalCDC Local Coding Systemactive2023-06hl7
hl7.terminologyR5NamingSystem/HIPPSHealth Insurance Prospective Payment System (HIPPS)active2022-05hl7
hl7.terminologyR5NamingSystem/MVXManufacturers of Vaccines (MVX)active2024-10hl7
hl7.terminologyR5NamingSystem/CLIAClinical Laboratory Improvement Amendmentsactive2022-08hl7
hl7.terminologyR5NamingSystem/CDPSChronic Illness and Disability Payment System (CDPS)active2023-08hl7
hl7.terminologyR5NamingSystem/CAPeCCCollege of American Pathologists (CAP) eCC (electronic Cancer Checklists)active2022-07hl7
hl7.terminologyR5NamingSystem/DUNSNumberData Universal Numbering System (DUNS) Numberactive2024-10hl7
hl7.terminologyR5NamingSystem/FIPS64Federal Information Processing Standards Publication: Counties and Equivalent Entities of the United States, Its Possessions, and Associated Areas (FIPS 6-4)active2024-10hl7
hl7.terminologyR5NamingSystem/HGNCGeneGroupHUGO Gene Nomenclature Committee Gene Groupactive2024-08hl7
hl7.terminologyR5NamingSystem/v3-hgncHUGO Gene Nomenclature Committee Genesactive2024-08hl7
hl7.terminologyR5NamingSystem/hcp-lan-apm-frameworkThe Health Care Payment Learning and Action Network (HCPLAN) Alternative Payment Model (APM) Framework Categoriesactive2024-03hl7
hl7.terminologyR5NamingSystem/HPOHuman Phenotype Ontologyactive2022-06hl7
hl7.terminologyR5NamingSystem/ICFDutInternational Classification of Functioning, Disability and Health, Dutch Translationactive2022-10hl7
hl7.terminologyR5NamingSystem/ICFInternational Classification of Functioning, Disability and Healthactive2022-10hl7
hl7.terminologyR5NamingSystem/OpenEligibilityTaxonomyOpen Eligibility Taxonomyactive2023-04hl7
hl7.terminologyR5NamingSystem/SOSequence Ontologyactive2023-12hl7
hl7.terminologyR5NamingSystem/AHANUBCPriorityTypeOfAdmitOrVisitAHA NUBC Priority (Type) of Admission or Visitactive2022-05hl7
hl7.terminologyR5NamingSystem/AHANUBCPointOfOriginNewbornAHA NUBC Point of Origin for Newbornactive2022-05hl7
hl7.terminologyR5NamingSystem/AHANUBCPointOfOriginNonnewbornAHA NUBC Point of Origin for Non-newbornactive2022-05hl7
hl7.terminologyR5NamingSystem/AHANUBCPatientDischargeStatusAHA NUBC Patient Discharge Status Codesactive2022-05hl7
hl7.terminologyR5NamingSystem/AHANUBCConditionCodesAHA NUBC Condition Codesactive2024-10hl7
hl7.terminologyR5NamingSystem/AHANUBCValueCodesAndAmountsAHA NUBC Value Codes and Amountsactive2024-10hl7
hl7.terminologyR5NamingSystem/AHANUBCRevenueCodesAHA NUBC Revenue Codesactive2022-05hl7
hl7.terminologyR5NamingSystem/PharmVarPharmacogene Variationactive2024-04hl7
hl7.terminologyR5NamingSystem/FIPS52Federal Information Processing Standards Publication: Codes for the Identification of the States, the District of Columbia and the Outlying Areas of the United States, and Associated Areas (FIPS 5-2)active2024-10hl7
hl7.terminologyR5NamingSystem/X12AmbulanceTransportReasonCodesX12 Ambulance Transport Reason Codesactive2024-09hl7
hl7.terminologyR5NamingSystem/X12ClaimAdjustmentReasonCodesX12 Claim Adjustment Reason Codesactive2022-05hl7
hl7.terminologyR5NamingSystem/X12ServiceTypeCodesX12 Service Type Codesactive2023-06hl7
hl7.terminologyR5NamingSystem/W3CDIDW3C Decentralized Identifier (DID)active2022-11hl7
hl7.terminologyR5NamingSystem/csaidCAN/CSA-Z795-96retired2021-07hl7
hl7.terminologyR5NamingSystem/iso639-1ISO 639-1: Codes for the representation of names of languages -- Part 1: Alpha-2 coderetired2021-11hl7
hl7.terminologyR5NamingSystem/iso639-2ISO 639-2: Codes for the representation of names of languages -- Part 2: Alpha-3 coderetired2021-11hl7
hl7.terminologyR5NamingSystem/opinionsOnline Product Identification Number Index of Nova Scotiaactive2021-07hl7
hl7.terminologyR5NamingSystem/iso639-3ISO 639-3 Language Codes Alpha 3retired2021-11hl7
hl7.terminologyR5NamingSystem/ahfsAHFS Pharmacologic-Therapeutic Classificationretired2021-11hl7
hl7.terminologyR5NamingSystem/EPSG-GeodeticParameterDatasetEPSG Geodetic Parameter Datasetretired2021-11hl7
hl7.terminologyR5NamingSystem/SCDHEC-GISSpatialAccuracyTiersSCDHEC GIS Spatial Accuracy Tiersretired2021-11hl7
hl7.terminologyR5NamingSystem/epsg-crsEuropean Petroleum Survey Group Geodetic Parameter Dataset Coordinate Reference Systemretired2021-11hl7
hl7.terminologyR5NamingSystem/epsg-caEuropean Petroleum Survey Group Geodetic Parameter Dataset Coordinate Axisretired2021-11hl7
hl7.terminologyR5NamingSystem/PHIndustryCDCCensus2010Industry CDC Census 2010active2019-03hl7
hl7.terminologyR5NamingSystem/PHOccupationCDCCensus2010Occupation CDC Census 2010active2019-03hl7
hl7.terminologyR5NamingSystem/APRDRGAll Patient Refined Diagnosis Related Groups (APR DRGs)active2020-11hl7
hl7.terminologyR5NamingSystem/ca-hc-dinHealth Canada Drug Id Numberactive2021-10hl7
hl7.terminologyR5NamingSystem/NCPDPProviderIdentificationNumberNCPDP Provider Identification Numberactive2021-03hl7
hl7.terminologyR5NamingSystem/UNIIUnique Ingredient Identifier (UNII)active2022-08hl7
hl7.terminologyR5NamingSystem/usb-address-identifierUSB VID and PID as a device identifieractive2021-06hl7
hl7.terminologyR5NamingSystem/hslocNHSN Healthcare Facility Patient Care Locationactive2021-02hl7
hl7.terminologyR5NamingSystem/v3-SpecialArrangementSpecialArrangementactive2019-03hl7
hl7.terminologyR5NamingSystem/metabolicSyndromeMETABOLIC SYNDROMEretired2021-11hl7
hl7.terminologyR5NamingSystem/icpc2-icd10-THSRSICPC2-ICD10 Thesaurusretired2021-11hl7
hl7.terminologyR5NamingSystem/CDCNHSNNHSN Surveillance System Codesactive2021-03hl7
hl7.terminologyR5NamingSystem/AS4EAS4 Neurophysiology Codesretired2021-11hl7
hl7.terminologyR5NamingSystem/AS4ASTM E1238/E1467 Universalretired2021-11hl7